Stock Information
TG Therapeutics Inc (TGTX)
Ticker Symbol: TGTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $4,774.25 mil
Piotroski score: 3
PE Ratio: 11.6719
EPS (TTM): 2.777
Revenue (TTM): $3.87 M
Dividend Yield: N/A%
ROE: 101.12%
Latest News
-
TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside
Tue, Mar 31, 2026 7:07 PM
Key Financials
Financial data not available